These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22545010)

  • 1. Investigation of dose minimisation protocol for 18F-FDG PET-CT in the management of lymphoma postchemotherapy followup.
    Sonoda LI; Sanghera B; Wong WL
    ScientificWorldJournal; 2012; 2012():208135. PubMed ID: 22545010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
    Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
    Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
    BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist.
    Beadsmoore C; Newman D; MacIver D; Pawaroo D
    Can Assoc Radiol J; 2015 Nov; 66(4):332-47. PubMed ID: 26277234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.
    Kong G; Jackson C; Koh DM; Lewington V; Sharma B; Brown G; Cunningham D; Cook GJ
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1323-9. PubMed ID: 18347794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
    Ponisio MR; McConathy J; Laforest R; Khanna G
    Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?
    Hanna GG; Carson KJ; Lynch T; McAleese J; Cosgrove VP; Eakin RL; Stewart DP; Zatari A; O'Sullivan JM; Hounsell AR
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1040-51. PubMed ID: 20350798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma.
    Karunanithi S; Sharma P; Roy SG; Vettiyil B; Sharma A; Thulkar S; Bal C; Kumar R
    Clin Nucl Med; 2014 Sep; 39(9):772-6. PubMed ID: 25036015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT and renal pathology: a blind spot for radiologists? Part 2--lymphoma, leukemia, and metastatic disease.
    Zukotynski K; Lewis A; O'Regan K; Jacene H; Sakellis C; Almodovar S; Israel D
    AJR Am J Roentgenol; 2012 Aug; 199(2):W168-74. PubMed ID: 22826418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.
    Ömür Ö; Baran Y; Oral A; Ceylan Y
    Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma.
    Qi Z; Gates EL; O'Brien MM; Trout AT
    Pediatr Radiol; 2018 Feb; 48(2):196-203. PubMed ID: 29080987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of FDG-PETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIV-infected patients.
    Westwood TD; Hogan C; Julyan PJ; Coutts G; Bonington S; Carrington B; Taylor B; Khoo S; Bonington A
    Eur J Radiol; 2013 Aug; 82(8):e374-9. PubMed ID: 23578921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma.
    Tirumani SH; LaCasce AS; Jacene HA
    PET Clin; 2015 Apr; 10(2):207-25. PubMed ID: 25829087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
    Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS
    Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results.
    Schäfer JF; Gatidis S; Schmidt H; Gückel B; Bezrukov I; Pfannenberg CA; Reimold M; Ebinger M; Fuchs J; Claussen CD; Schwenzer NF
    Radiology; 2014 Oct; 273(1):220-31. PubMed ID: 24877983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.
    Mena E; Lindenberg ML; Turkbey BI; Shih J; Logan J; Adler S; Wong K; Wilson W; Choyke PL; Kurdziel KA
    Clin Nucl Med; 2014 Oct; 39(10):874-81. PubMed ID: 25144214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
    Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
    Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.